Rubicon Organics Inc. (TSXV: ROMJ | OTCQX: ROMJF), a Vancouver-based premium cannabis producer, held its Annual General Meeting on September 24, 2026, with shareholders approving all matters on the ballot. Approximately 39.1% of issued and outstanding common shares were represented at the meeting, totalling 26,439,140 shares voted. The results confirm a refreshed five-member board and the reappointment of PricewaterhouseCoopers LLP as auditor, alongside the departure of three long-serving directors.

Key Points

  • Rubicon Organics Inc. (TSXV: ROMJ | OTCQX: ROMJF) held its Annual General Meeting on September 24, 2026
  • Shareholders approved a five-member board and reappointed PricewaterhouseCoopers LLP as auditor with 100% support
  • Directors Len Boggio, Ian Gordon, and Karen Proud retired from the board effective the same day
  • Investors may be watching the company's renewed research engagement with Atrium Research Corporation, pending TSX-V approval

Voting Results and Board Election at Rubicon Organics' 2026 AGM

All five director nominees — Doris Bitz, Jesse McConnell, John Pigott, Margaret Brodie, and Michael Detlefsen — were elected with strong shareholder support. Vote tallies ranged from 92.8% in favour for John Pigott to 99.2% for Doris Bitz. The resolution to set the number of directors at five received 99.8% approval, while the appointment of PricewaterhouseCoopers LLP as auditor was approved unanimously at 100%. The disclosure confirms all matters presented in the management information circular dated August 19, 2026, were approved by shareholders.

Three Directors Retire as Rubicon Organics Refreshes Its Governance Structure

Len Boggio, Ian Gordon, and Karen Proud did not stand for re-election and retired from the board effective September 24, 2026. Board Chair Doris Bitz acknowledged their contributions in the release, stating the company wished to thank each departing director for their dedicated service and guidance through important stages of the company's development. The release includes a direct quote from Bitz expressing appreciation for their experience and commitment. No further details regarding the governance transition were disclosed in the announcement.

Rubicon Organics Renews Atrium Research Corporation Engagement

The company announced it has renewed a research services agreement with Atrium Research Corporation, an independent third-party firm. Under the terms disclosed, Atrium will receive $10,500 per quarter over a 12-month period beginning October 1, 2026. The release states the engagement is subject to TSX-V approval and confirms that Atrium and the company are arm's-length parties. Neither Atrium nor its insiders holds shares or options in Rubicon Organics. The immediate share price impact was not clear from available public information.